Details for Patent: 8,017,150

Title:	Polyethylene oxide-based films and drug delivery systems made therefrom
Abstract:	The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. The films contain a polymer component, which includes polyethylene oxide optionally blended with hydrophilic cellulosic polymers. Desirably, the films also contain a pharmaceutical and/or cosmetic active agent with no more than a 10% variance of the active agent pharmaceutical and/or cosmetic active agent per unit area of the film.
Inventor(s):	Yang; Robert K. (Flushing, NY), Fuisz; Richard C. (McLean, VA), Myers; Garry L. (Kingsport, TN), Fuisz; Joseph M. (Washington, DC)
Assignee:	MonoSol Rx, LLC (Portage, IN)
Filing Date:	Apr 22, 2008
Application Number:	12/107,389
Claims:	1. A mucosally-adhesive water-soluble film product comprising: an analgesic opiate pharmaceutical active; and at least one water-soluble polymer component consisting of polyethylene oxide in combination with a hydrophilic cellulosic polymer; wherein: the water-soluble polymer component comprises greater than 75% polyethylene oxide and up to 25% hydrophilic cellulosic polymer; the polyethylene oxide comprises one or more low molecular weight polyethylene oxides and one or more higher molecular weight polyethylene oxides, the molecular weight of the low molecular weight polyethylene oxide being in the range 100,000 to 300,000 and the molecular weight of the higher molecular weight polyethylene oxide being in the range 600,000 to 900,000; and the polyethylene oxide of low molecular weight comprises about 60% or more in the polymer component. 2. The film product according to claim 1, wherein said film product has a viscosity of about 1,000 cps to about 40,000 cps. 3. The film product according to claim 1, wherein said film product has a thickness of about 3 mils to about 6 mils. 4. The film product according to claim 1, further comprising an additional pharmaceutical active. 5. The film product according to claim 1, further comprising one or more sweeteners. 6. The film product according to claim 5, wherein said one or more sweeteners comprise a hydrogenated starch hydrolysate. 7. The film product according to claim 5, wherein said one or more sweeteners comprise the potassium salt of 3,6-dihydro-6-methyl-1-1-1,2,3-oxathiazin-4-one-2,2-dioxide. 8. The film product according to claim 1, further comprising one or more flavors. 9. The film product according to claim 1, further comprising one or more buffers. 10. A mucosally-adhesive water-soluble film product comprising: an analgesic opiate pharmaceutical active; and at least one water-soluble polymer component consisting of polyethylene oxide in combination with a hydrophilic cellulosic polymer; wherein: the water-soluble polymer component comprises the hydrophilic cellulosic polymer in a ratio of up to about 4:1 with the polyethylene oxide; the polyethylene oxide comprises one or more low molecular weight polyethylene oxides and one or more higher molecular weight polyethylene oxides, the molecular weight of the low molecular weight polyethylene oxide being in the range 100,000 to 300,000 and the molecular weight of the higher molecular weight polyethylene oxide being in the range 600,000 to 900,000; and the polyethylene oxide of low molecular weight comprises about 60% or more in the polymer component. 11. The film product according to claim 10, wherein said film product has a viscosity of about 1,000 cps to about 40,000 cps. 12. The film product according to claim 10, wherein said film product has a thickness of about 3 mils to about 6 mils. 13. The film product according to claim 10, further comprising an additional pharmaceutical active. 14. The film product according to claim 10, further comprising one or more sweeteners. 15. The film product according to claim 14, wherein said one or more sweeteners comprise a hydrogenated starch hydrolysate. 16. The film product according to claim 14, wherein said one or more sweeteners comprise the potassium salt of 3,6-dihydro-6-methyl-1-1-1,2,3-oxathiazin-4-one-2,2-dioxide. 17. The film product according to claim 10, further comprising one or more flavors. 18. The film product according to claim 10, further comprising one or more buffers.